Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization

ClinicalTrials.gov ID: NCT02479620

Public ClinicalTrials.gov record NCT02479620. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 12:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

LIMBO-ATX: Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a prospective, multi-center, randomized pilot study to document the effects of adventitial delivery of dexamethasone after atherectomy-based revascularizations of lesions below the knee in symptomatic patients with critical limb ischemia (CLI).

Study identification

NCT ID
NCT02479620
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mercator MedSystems, Inc.
Industry
Enrollment
120 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2016 (Actual)
Primary completion
Nov 2019 (Actual)
Completion
Mar 2020 (Estimated)
Last update posted
Feb 19, 2020

2016 – 2020

United States locations

U.S. sites
10
U.S. states
10
U.S. cities
10
Facility City State ZIP Site status
Arkansas Heart Hospital Little Rock Arkansas 72211 —
Denver Veterans Administration Hospital Denver Colorado 80220 —
Mid-Michigan Heart & Vascular Saginaw Michigan 48604 —
Hattiesburg Clinic Hattiesburg Mississippi 39401 —
St.Louis University Hospital St Louis Missouri 63110 —
Holy Name Medical Center Teaneck New Jersey 07666 —
UNC Health Care - Rex Hospital Raleigh North Carolina 27607 —
Sanford Research Sioux Falls South Dakota 57101 —
Tennova - Turkey Creek Medical Center Knoxville Tennessee 37934 —
Mission Research Institute (New Braunfels Cardiology - GRMC) New Braunfels Texas 78130 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02479620, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2020 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02479620 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →